Our OEB-5 (Operational Exposure Band, level 5) manufacturing facility designed, built and operated with strict adherence to cGMP to meet and exceed international standards. Currently we are focusing to strengthen our capability with right motivation as we are going for EU submission by 2020. We have an expert team having sound technical knowledge and working experiences in different countries made them undoubtedly fit to run our facilities as per the requirements.
In order to grab the opportunities in global Oncology generic market, our Oncology and Anti-retroviral products are already into international markets around the world.
We are also open for collaboration, partnership and contract manufacturing for oncology products around the world.